警惕免疫疗法毒性：伊匹单抗/尼妥珠单抗治疗引起的单侧眼睑下垂病例

Journal of Immunotherapy and Precision Oncology Pub Date : 2024-03-01 DOI:10.36401/jipo-23-44

Khalid Jazieh, Lisa Kottschade, Anastasios Dimou

{"title":"警惕免疫疗法毒性：伊匹单抗/尼妥珠单抗治疗引起的单侧眼睑下垂病例","authors":"Khalid Jazieh, Lisa Kottschade, Anastasios Dimou","doi":"10.36401/jipo-23-44","DOIUrl":null,"url":null,"abstract":"\n Despite ocular adverse events from immune checkpoint inhibitors being uncommon, they are still important complications to be aware of. We present the case of metastatic melanoma on ipilimumab/nivolumab in a patient who developed immunotherapy complications with delayed diagnosis because the only presenting symptom was unilateral ptosis. We reviewed the literature for relevant and important ocular and neurological complications of immune checkpoint inhibitors.","PeriodicalId":506669,"journal":{"name":"Journal of Immunotherapy and Precision Oncology","volume":"34 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy\",\"authors\":\"Khalid Jazieh, Lisa Kottschade, Anastasios Dimou\",\"doi\":\"10.36401/jipo-23-44\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Despite ocular adverse events from immune checkpoint inhibitors being uncommon, they are still important complications to be aware of. We present the case of metastatic melanoma on ipilimumab/nivolumab in a patient who developed immunotherapy complications with delayed diagnosis because the only presenting symptom was unilateral ptosis. We reviewed the literature for relevant and important ocular and neurological complications of immune checkpoint inhibitors.\",\"PeriodicalId\":506669,\"journal\":{\"name\":\"Journal of Immunotherapy and Precision Oncology\",\"volume\":\"34 10\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Immunotherapy and Precision Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36401/jipo-23-44\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Immunotherapy and Precision Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36401/jipo-23-44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

尽管免疫检查点抑制剂引起的眼部不良反应并不常见，但它们仍然是需要注意的重要并发症。我们介绍了一例使用伊匹单抗/nivolumab的转移性黑色素瘤患者的病例，该患者出现免疫治疗并发症并延迟诊断，因为唯一的症状就是单侧眼睑下垂。我们回顾了与免疫检查点抑制剂相关的重要眼部和神经系统并发症文献。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Keeping an Eye Out for Immunotherapy Toxicity: A Case of Unilateral Ptosis Caused by Ipilimumab/Nivolumab Therapy

Despite ocular adverse events from immune checkpoint inhibitors being uncommon, they are still important complications to be aware of. We present the case of metastatic melanoma on ipilimumab/nivolumab in a patient who developed immunotherapy complications with delayed diagnosis because the only presenting symptom was unilateral ptosis. We reviewed the literature for relevant and important ocular and neurological complications of immune checkpoint inhibitors.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Immunotherapy and Precision Oncology

自引率

0.00%

发文量